Home 2018-06-07T14:20:03+00:00

Introducing a cure for chronic ulcerated wounds

CHRONIC ULCERATED LEG WOUNDS
PREVENT AMPUTATIONS

Introducing a cure for chronic ulcerated wounds

CHRONIC ULCERATED LEG WOUNDS
PREVENT AMPUTATIONS

Our Offering

BioRegentech rapidly regenerates chronic wound tissue and closes wounds in limbs which are currently routinely recommended to be amputated such as diabetic foot and leg ulcers.

Advanced wound care products are very confusing and there are many out on the market designed to assist the healing of chronic wounds. Practitioners are confused because a single product does not work and cases do not close. Instead, the patient comes back weekly to have wounds scraped, vacuumed, oxygenated… you name it… in order to prevent infection or amputations. Due to lack of successful treatment, physical therapy for wounds has recently come about.

BioRegentech simplifies the process to doctors by providing a single system with a healing time measured in weeks to months as opposed to forever, significantly cutting hospital and clinic time to a mere fraction of the current cycle. Our proprietary system regenerates circulation enabling chronic wounds to “enjoy” blood supply, prevents infection, regenerates chronic wound tissue such as necrotic black tissue, and CLOSES ADVANCED WOUNDS that are many inches in diameter WITHOUT A GRAFT.

Corporate Profile

Dr. Margaret Kalmeta
Chief Science Officer

Steve Merrick
Chief Executive Officer

Christine Pasciak
Chief Operations Officer

Robert Holmes
Medical Device Expert

Daniel Zientara
Engineer

Mike Smur
Marketing Director

Wendy Weidman
Medical Imaging/Publishing

Pawel Godlewski
Animation, Tutorials

Agnes Dobrzycka
Germany/Europe Division

Daniella Bonilla
Costa Rica/South America Division

Dr. Alex Retana
Costa Rica/South America Division

Sarah Kalmeta
Asia Division

Dr. Brad Woodford
US VA Hospital Division

Anthony Kalmeta
Film-Case Tutorials/Testimonials

Erica Kalmeta
Photography/Uniform Background/Lighting

Dr. Margaret Kalmeta
Chief Science Officer

Steve Merrick
Chief Executive Officer

Christine Pasciak
Chief Operations Officer

Robert Holmes
Medical Device Expert

Daniel Zientara
Engineer

Mike Smur
Marketing Director

Wendy Weidman
Medical Imaging/Publishing

Pawel Godlewski
Animation, Tutorials

Agnes Dobrzycka
Germany/Europe Division

Daniella Bonilla
Costa Rica/South America Division

Dr. Alex Retana
Costa Rica/South America Division

Sarah Kalmeta
Asia Division

Dr. Brad Woodford
US VA Hospital Division

Anthony Kalmeta
Film-Case Tutorials/Testimonials

Erica Kalmeta
Photography/Uniform Background/Lighting

Our Mission

Our mission is to restore health to humanity by regenerating wounds and restoring the wounded body part to its’ original morphology.

Investor Materials

PROBLEM

An increasing amount of patients, currently 6.5 million in the US alone, suffer from chronic non-healing wounds. Patients must return to their doctor weekly forever to have wounds scraped, vacuumed and oxygenated with the aim of preventing infections, amputations, and morbidity at a yearly cost of billions to the global medical community due to lack of cure. Global advanced wound care market is expected to reach $22 billion by 2022.

SOLUTION

BioRegentech developed diagnostic tools, medical devices and biologics and is now able to offer doctors the ability to cure advanced chronic wounds, shortening treatment time from forever to weeks or months, at a yearly medical spending savings in the billions of dollars. A cure now is especially relevant because the incidence of chronic wounds is signficantly on the rise due to a rapidly increasing rate of diabetes, obesity and the increasing age of our populations.

Contact Us

Please fill out the quick form below you have any questions about our regenerative technologies or are interested in discussing a potential partnership.